What Happened?
Shares of medical device company ICU Medical (NASDAQ: ICUI) jumped 10.2% in the afternoon session after the company posted strong second-quarter results that surpassed Wall Street expectations and raised its full-year earnings forecast.
The medical device maker reported adjusted earnings of $2.37 per share, handily beating the average analyst estimate of $1.91. Revenue for the period was $551.7 million, up 1.5% year on year and also topping forecasts. A key highlight from the quarter was the significant improvement in cash flow. Free cash flow was $61.64 million, a strong recovery from a negative $8.49 million in the same quarter last year.
Following the strong performance, ICU Medical lifted its full-year adjusted earnings guidance to $8.80 per share at the midpoint, beating previous analyst estimates.
Is now the time to buy ICU Medical? Access our full analysis report here, it’s free.
What Is The Market Telling Us
ICU Medical’s shares are not very volatile and have only had 6 moves greater than 5% over the last year. Moves this big are rare for ICU Medical and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 12 months ago when the stock dropped 10.5% on the news that the company reported second-quarter results where a significant earnings beat was overshadowed by a year-over-year revenue decline and concerning cash flow performance. The medical device company reported a GAAP profit of $1.43 per share, significantly reversing a loss from the prior year and handily beating analyst expectations. However, investors appeared to focus on the 8% year-over-year decline in revenue, which landed at $548.9 million, even though it slightly surpassed analyst forecasts. Furthermore, the company's free cash flow was a negative $8.49 million, a stark reversal from a positive $62.67 million in the same period last year, indicating pressure on its cash generation. Despite the company also issuing full-year profit guidance that was well ahead of Wall Street estimates, the revenue dip and negative cash flow seemingly weighed more heavily on investor sentiment.
ICU Medical is up 31.5% since the beginning of the year, and at $182.16 per share, it has set a new 52-week high. Despite the year-to-date gain, investors who bought $1,000 worth of ICU Medical’s shares 5 years ago would now be looking at only $941.32.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
